Guangdong, China

Bifei He

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.9

ph-index = 1


Location History:

  • Guangdong, CN (2020)
  • Dongguan, CN (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Bifei He: Innovator in Pharmaceutical Compounds

Introduction

Bifei He is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 3 patents to his name, his work has implications for various therapeutic applications.

Latest Patents

Bifei He's latest patents include innovative compounds and their preparation methods. One of his notable inventions is related to diaryl thioether piperazine compounds, which includes a preparation method and their uses. Specifically, this compound is represented by a formula where HX is a fatty acid or pamoic acid. Another significant patent involves memantine compounds, which encompasses a formula for these compounds, including stereoisomers, deuterated analogs, and pharmaceutically acceptable salts, along with methods of making and using them.

Career Highlights

Throughout his career, Bifei He has worked with prominent companies in the pharmaceutical industry. He has been associated with Sunshine Lake Pharma Co., Ltd. and North & South Brother Pharmacy Investment Company Limited. His work in these organizations has allowed him to contribute to the advancement of pharmaceutical research and development.

Collaborations

Bifei He has collaborated with several professionals in his field, including Zhonghua Luo and Yuping Fan. These collaborations have likely enhanced his research and innovation efforts, leading to the successful development of his patented compounds.

Conclusion

Bifei He is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact therapeutic practices significantly. His innovative patents and collaborations reflect his commitment to advancing the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…